{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:06:18Z","timestamp":1791957978020,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.sapharm.2011.08.002","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T19:45:10Z","timestamp":1323114310000},"page":"309-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identifying iatrogenic depression using confirmatory factor analysis of the Center for Epidemiologic Studies Depression Scale in patients prescribed a verapamil-sustained-release-led or atenolol-led hypertension treatment strategy"],"prefix":"10.1016","volume":"8","author":[{"given":"Debbie L.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Douglas","family":"Ried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2011.08.002_bib1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.sapharm.2011.08.002_bib2","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with\u00a0coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2011.08.002_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.288.3.351","article-title":"Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction","volume":"288","author":"Ko","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2011.08.002_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1345\/aph.17185","article-title":"Beta-blockers and depression: the more the murkier?","volume":"32","author":"Ried","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2011.08.002_bib5","series-title":"Drug Information Handbook 2000-2001","author":"Lacy","year":"2000"},{"key":"10.1016\/j.sapharm.2011.08.002_bib6","series-title":"Physicians' Desk Reference","year":"2007"},{"key":"10.1016\/j.sapharm.2011.08.002_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/jama.1986.03370030077031","article-title":"Increased antidepressant use in patients prescribed beta-blockers","volume":"255","author":"Avorn","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2011.08.002_bib8","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/archinte.1990.00390220044009","article-title":"Increased prescribing of antidepressants subsequent to beta-blocker therapy","volume":"150","author":"Thiessen","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2011.08.002_bib9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1001\/jama.1992.03480130099032","article-title":"Beta-blockers and depression. Evidence against an association","volume":"267","author":"Bright","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2011.08.002_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0895-4356(96)00017-0","article-title":"The incidence of depression in new users of beta-blockers and selected antihypertensives","volume":"49","author":"Gerstman","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2011.08.002_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.316.7133.741","article-title":"Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study","volume":"316","author":"Lindberg","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2011.08.002_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/03610739208253916","article-title":"A practical guide to measurement invariance in aging research","volume":"18","author":"Horn","year":"1992","journal-title":"Exp Aging Res"},{"key":"10.1016\/j.sapharm.2011.08.002_bib13","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.161.15.1849","article-title":"Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure","volume":"161","author":"Jiang","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2011.08.002_bib14","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1046\/j.1532-5415.2002.50612.x","article-title":"Prevalence and correlates of depressive symptoms in a community sample of people suffering from heart failure","volume":"50","author":"Turvey","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2011.08.002_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.CIR.0000152102.29293.D7","article-title":"Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery","volume":"111","author":"Mallik","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2011.08.002_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.psy.0000146332.53619.b2","article-title":"Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis","volume":"66","author":"Barth","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.sapharm.2011.08.002_bib17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/01.psy.0000146294.82810.9c","article-title":"Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis","volume":"66","author":"van Melle","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.sapharm.2011.08.002_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/oxfordjournals.aje.a114408","article-title":"Depressive symptoms in relation to physical health and functioning in the elderly","volume":"124","author":"Berkman","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sapharm.2011.08.002_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2307\/2137178","article-title":"Physical disability and depression: a longitudinal analysis","volume":"29","author":"Turner","year":"1998","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.sapharm.2011.08.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J055v08n01_01","article-title":"Antihypertensive drug use and the risk of depression among older hypertensives in an HMO","volume":"8","author":"Ried","year":"2000","journal-title":"J Pharmacoepidemiol"},{"key":"10.1016\/j.sapharm.2011.08.002_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/clpt.1987.83","article-title":"Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial","volume":"41","author":"Davis","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.sapharm.2011.08.002_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.psy.0000160468.69451.7f","article-title":"A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST)","volume":"67","author":"Ried","year":"2005","journal-title":"Psychosom Med"},{"key":"10.1016\/j.sapharm.2011.08.002_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas"},{"key":"10.1016\/j.sapharm.2011.08.002_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a112455","article-title":"Assessing depressive symptoms in five psychiatric populations: a validation study","volume":"106","author":"Weissman","year":"1977","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sapharm.2011.08.002_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2648.2002.02378.x","article-title":"Screening for depression in a hepatitis C population: the reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D)","volume":"40","author":"Clark","year":"2002","journal-title":"J\u00a0Adv Nurs"},{"key":"10.1016\/j.sapharm.2011.08.002_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1440-1819.2003.01103.x","article-title":"Childhood parental separation experiences and depressive symptomatology in acute major depression","volume":"57","author":"Takeuchi","year":"2003","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.sapharm.2011.08.002_bib27","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1093\/geronj\/44.3.S110","article-title":"Generational differences in the structure of the CES-D scale in Mexican Americans","volume":"44","author":"Liang","year":"1989","journal-title":"J Gerontol"},{"key":"10.1016\/j.sapharm.2011.08.002_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.sapharm.2007.04.003","article-title":"Core reporting practices in structural equation modeling","volume":"4","author":"Schreiber","year":"2008","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.sapharm.2011.08.002_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/109442810031002","article-title":"A review and synthesis of the measurement invariance literature: suggestions, practices, and recommendations for organizational research","volume":"3","author":"Vandenberg","year":"2000","journal-title":"Organ Res Methods"},{"key":"10.1016\/j.sapharm.2011.08.002_bib30","series-title":"Principles and Practice of Structural Equation Modeling","author":"Kline","year":"2005"},{"key":"10.1016\/j.sapharm.2011.08.002_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives","volume":"6","author":"Hu","year":"1999","journal-title":"Struct Equ Modeling"},{"key":"10.1016\/j.sapharm.2011.08.002_bib32","series-title":"Testing Structural Equation Models","first-page":"136","article-title":"Alternative ways of assessing model fit","author":"Browne","year":"1993"},{"key":"10.1016\/j.sapharm.2011.08.002_bib33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1207\/s15328007sem1303_3","article-title":"Confirmatory factor analytic procedures for the determination of measurement invariance","volume":"13","author":"French","year":"2006","journal-title":"Struct Equ Modeling"},{"key":"10.1016\/j.sapharm.2011.08.002_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1037\/0033-2909.103.3.411","article-title":"Structural equation modeling in practice: a review and recommended two-step approach","volume":"103","author":"Anderson","year":"1988","journal-title":"Psychol Bull"},{"key":"10.1016\/j.sapharm.2011.08.002_bib35","series-title":"Principles and Practices of Structural Equation Modeling","author":"Kline","year":"1998"},{"key":"10.1016\/j.sapharm.2011.08.002_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1207\/s15328007sem1203_7","article-title":"Testing measurement invariance of a second-order factor model: an illustration using a measure of quality of life","volume":"12","author":"Chen","year":"2005","journal-title":"Struct Equ Modeling"},{"key":"10.1016\/j.sapharm.2011.08.002_bib37","series-title":"Structural Equation Modeling","year":"1995"},{"key":"10.1016\/j.sapharm.2011.08.002_bib38","unstructured":"Gold Standard, Incorporated. (2007). Verapamil. Clinical Pharmacology [database online]. Available at: http:\/\/www.clinicalpharmacology.com. Accessed 18.09.07. 8-6-0007."},{"key":"10.1016\/j.sapharm.2011.08.002_bib39","unstructured":"Gold Standard, Incorporated. (2007). Atenolol. Clinical Pharmacology [database online]. Available at: http:\/\/www.clinicalpharmacology.com. Accessed 18.09.07. 6-17-0007."},{"key":"10.1016\/j.sapharm.2011.08.002_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1207\/s15327752jpa8601_03","article-title":"Unidimensionality and bandwidth in the Center for Epidemiologic Studies Depression (CES-D) Scale","volume":"86","author":"Stansbury","year":"2006","journal-title":"J Pers Assess"},{"key":"10.1016\/j.sapharm.2011.08.002_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0002-8703(87)90973-2","article-title":"Use of beta blockers in postinfarct prophylaxis: aspects on quality of life, occurrence of anterior ST depression in inferior myocardial infarction and relation to clinical outcome","volume":"114","author":"Hjalmarson","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.sapharm.2011.08.002_bib42","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0002-9149(87)90607-2","article-title":"Major depressive disorder in coronary artery disease","volume":"60","author":"Carney","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.sapharm.2011.08.002_bib43","first-page":"481","article-title":"Depression associated with antihypertensive drugs","volume":"33","author":"Prisant","year":"1991","journal-title":"J Fam Pract"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741111001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741111001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:07:19Z","timestamp":1761556039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741111001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1551741111001033"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2011.08.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying iatrogenic depression using confirmatory factor analysis of the Center for Epidemiologic Studies Depression Scale in patients prescribed a verapamil-sustained-release-led or atenolol-led hypertension treatment strategy","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2011.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}